Do analysts recommend IOSP or NGVT?

Ingevity has a consensus target price of $80.00, indicating a potential upside of 18.81%. Given Ingevity's stronger consensus rating and higher possible upside, analysts plainly believe Ingevity is more favorable than Innospec. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innospec 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Ingevity 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Which has preferable valuation & earnings, IOSP or NGVT?

Innospec has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Innospec $1.78B 1.13 $116.60M $4.59 17.78 Ingevity $1.17B 2.01 -$167.10M -$3.55 N/A

Is IOSP or NGVT more profitable?

Innospec has a net margin of 6.38% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat Innospec's return on equity. Company Net Margins Return on Equity Return on Assets Innospec 6.38% 9.32% 6.79% Ingevity -10.55% 207.82% 9.70%

Which has stronger valuation and earnings, AVNT or NGVT?

Avient has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avient $3.26B 0.97 $81.90M $1.72 20.05 Ingevity $1.17B 2.01 -$167.10M -$3.55 N/A

Is AVNT or NGVT more profitable?

Avient has a net margin of 4.81% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat Avient's return on equity. Company Net Margins Return on Equity Return on Assets Avient 4.81% 11.11% 4.40% Ingevity -10.55% 207.82% 9.70%

Do analysts recommend NGVT or SCL?

Ingevity currently has a consensus target price of $80.00, indicating a potential upside of 18.81%. Given Ingevity's stronger consensus rating and higher probable upside, equities research analysts clearly believe Ingevity is more favorable than Stepan. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ingevity 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Stepan 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, NGVT or SCL?

Stepan has higher revenue and earnings than Ingevity. Stepan is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ingevity $1.17B 2.01 -$167.10M -$3.55 N/A Stepan $2.33B 0.51 $46.90M -$0.62 N/A

Is NGVT or SCL more profitable?

Stepan has a net margin of -0.61% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat Stepan's return on equity. Company Net Margins Return on Equity Return on Assets Ingevity -10.55% 207.82% 9.70% Stepan -0.61% 2.65% 1.37%

Which has stronger valuation and earnings, NGVT or TKR?

Timken has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Timken, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ingevity $1.17B 2.01 -$167.10M -$3.55 N/A Timken $4.58B 1.91 $288.40M $4.40 28.58

Is NGVT or TKR more profitable?

Timken has a net margin of 6.60% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat Timken's return on equity. Company Net Margins Return on Equity Return on Assets Ingevity -10.55% 207.82% 9.70% Timken 6.60% 11.84% 5.79%

Which has preferable valuation & earnings, NGVT or ICL?

ICL Group has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than ICL Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ingevity $1.17B 2.01 -$167.10M -$3.55 N/A ICL Group $7.15B 1.18 $226M $0.20 32.63

Is NGVT or ICL more profitable?

ICL Group has a net margin of 3.52% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat ICL Group's return on equity. Company Net Margins Return on Equity Return on Assets Ingevity -10.55% 207.82% 9.70% ICL Group 3.52% 7.84% 3.95%

Ingevity (NGVT) Competitors

$67.60 -0.99 (-1.44%)

As of 09:53 AM Eastern

Compare

NGVT vs. IOSP, AVNT, SCL, TKR, and ICL

Should you buy Ingevity stock or one of its competitors? MarketBeat compares Ingevity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ingevity include Innospec (IOSP), Avient (AVNT), Stepan (SCL), Timken (TKR), and ICL Group (ICL).

How does Ingevity compare to Innospec?

Innospec (NASDAQ:IOSP) and Ingevity (NYSE:NGVT) are both mid-cap basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Innospec has a beta of 0.92, meaning that its share price is 8% less volatile than the broader market. Comparatively, Ingevity has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market.

96.6% of Innospec shares are owned by institutional investors. Comparatively, 91.6% of Ingevity shares are owned by institutional investors. 1.5% of Innospec shares are owned by insiders. Comparatively, 0.9% of Ingevity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Innospec had 2 more articles in the media than Ingevity. MarketBeat recorded 2 mentions for Innospec and 0 mentions for Ingevity. Innospec's average media sentiment score of 1.78 beat Ingevity's score of 0.00 indicating that Innospec is being referred to more favorably in the media.

Company	Overall Sentiment
Innospec	Very Positive
Ingevity	Neutral

Innospec has a net margin of 6.38% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat Innospec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innospec	6.38%	9.32%	6.79%
Ingevity	-10.55%	207.82%	9.70%

Innospec has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innospec	$1.78B	1.13	$116.60M	$4.59	17.78
Ingevity	$1.17B	2.01	-$167.10M	-$3.55	N/A

Ingevity has a consensus target price of $80.00, indicating a potential upside of 18.81%. Given Ingevity's stronger consensus rating and higher possible upside, analysts plainly believe Ingevity is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innospec	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Innospec beats Ingevity on 9 of the 16 factors compared between the two stocks.

How does Ingevity compare to Avient?

Avient (NYSE:AVNT) and Ingevity (NYSE:NGVT) are both mid-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

In the previous week, Avient's average media sentiment score of 0.00 equaled Ingevity'saverage media sentiment score.

Company	Overall Sentiment
Avient	Neutral
Ingevity	Neutral

95.5% of Avient shares are held by institutional investors. Comparatively, 91.6% of Ingevity shares are held by institutional investors. 0.9% of Avient shares are held by insiders. Comparatively, 0.9% of Ingevity shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Avient currently has a consensus target price of $46.40, suggesting a potential upside of 34.56%. Ingevity has a consensus target price of $80.00, suggesting a potential upside of 18.81%. Given Avient's stronger consensus rating and higher possible upside, equities analysts plainly believe Avient is more favorable than Ingevity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avient	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Avient has a beta of 1.28, suggesting that its stock price is 28% more volatile than the broader market. Comparatively, Ingevity has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market.

Avient has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avient	$3.26B	0.97	$81.90M	$1.72	20.05
Ingevity	$1.17B	2.01	-$167.10M	-$3.55	N/A

Avient has a net margin of 4.81% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat Avient's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avient	4.81%	11.11%	4.40%
Ingevity	-10.55%	207.82%	9.70%

Summary

Avient beats Ingevity on 9 of the 13 factors compared between the two stocks.

How does Ingevity compare to Stepan?

Ingevity (NYSE:NGVT) and Stepan (NYSE:SCL) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability and valuation.

Ingevity currently has a consensus target price of $80.00, indicating a potential upside of 18.81%. Given Ingevity's stronger consensus rating and higher probable upside, equities research analysts clearly believe Ingevity is more favorable than Stepan.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Stepan	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Stepan has a net margin of -0.61% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat Stepan's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ingevity	-10.55%	207.82%	9.70%
Stepan	-0.61%	2.65%	1.37%

Ingevity has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market. Comparatively, Stepan has a beta of 0.96, suggesting that its stock price is 4% less volatile than the broader market.

In the previous week, Stepan had 1 more articles in the media than Ingevity. MarketBeat recorded 1 mentions for Stepan and 0 mentions for Ingevity. Ingevity's average media sentiment score of 0.00 equaled Stepan'saverage media sentiment score.

Company	Overall Sentiment
Ingevity	Neutral
Stepan	Neutral

91.6% of Ingevity shares are owned by institutional investors. Comparatively, 82.7% of Stepan shares are owned by institutional investors. 0.9% of Ingevity shares are owned by insiders. Comparatively, 6.6% of Stepan shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Stepan has higher revenue and earnings than Ingevity. Stepan is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ingevity	$1.17B	2.01	-$167.10M	-$3.55	N/A
Stepan	$2.33B	0.51	$46.90M	-$0.62	N/A

Summary

Ingevity beats Stepan on 9 of the 15 factors compared between the two stocks.

How does Ingevity compare to Timken?

Ingevity (NYSE:NGVT) and Timken (NYSE:TKR) are related mid-cap companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Timken has a net margin of 6.60% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat Timken's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ingevity	-10.55%	207.82%	9.70%
Timken	6.60%	11.84%	5.79%

In the previous week, Timken had 28 more articles in the media than Ingevity. MarketBeat recorded 28 mentions for Timken and 0 mentions for Ingevity. Timken's average media sentiment score of 1.03 beat Ingevity's score of 0.00 indicating that Timken is being referred to more favorably in the news media.

Company	Overall Sentiment
Ingevity	Neutral
Timken	Positive

91.6% of Ingevity shares are owned by institutional investors. Comparatively, 89.1% of Timken shares are owned by institutional investors. 0.9% of Ingevity shares are owned by company insiders. Comparatively, 8.1% of Timken shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Timken has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Timken, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ingevity	$1.17B	2.01	-$167.10M	-$3.55	N/A
Timken	$4.58B	1.91	$288.40M	$4.40	28.58

Ingevity presently has a consensus target price of $80.00, indicating a potential upside of 18.81%. Timken has a consensus target price of $139.13, indicating a potential upside of 10.65%. Given Ingevity's higher possible upside, research analysts clearly believe Ingevity is more favorable than Timken.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Timken	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67

Ingevity has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, Timken has a beta of 1.21, suggesting that its share price is 21% more volatile than the broader market.

Summary

Timken beats Ingevity on 11 of the 16 factors compared between the two stocks.

How does Ingevity compare to ICL Group?

Ingevity (NYSE:NGVT) and ICL Group (NYSE:ICL) are both mid-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

91.6% of Ingevity shares are held by institutional investors. Comparatively, 13.4% of ICL Group shares are held by institutional investors. 0.9% of Ingevity shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

ICL Group has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than ICL Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ingevity	$1.17B	2.01	-$167.10M	-$3.55	N/A
ICL Group	$7.15B	1.18	$226M	$0.20	32.63

Ingevity currently has a consensus price target of $80.00, suggesting a potential upside of 18.81%. ICL Group has a consensus price target of $6.60, suggesting a potential upside of 1.15%. Given Ingevity's stronger consensus rating and higher probable upside, research analysts clearly believe Ingevity is more favorable than ICL Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
ICL Group	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

ICL Group has a net margin of 3.52% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat ICL Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ingevity	-10.55%	207.82%	9.70%
ICL Group	3.52%	7.84%	3.95%

Ingevity has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, ICL Group has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market.

In the previous week, ICL Group had 2 more articles in the media than Ingevity. MarketBeat recorded 2 mentions for ICL Group and 0 mentions for Ingevity. Ingevity's average media sentiment score of 0.00 equaled ICL Group'saverage media sentiment score.

Company	Overall Sentiment
Ingevity	Neutral
ICL Group	Neutral

Summary

Ingevity beats ICL Group on 9 of the 15 factors compared between the two stocks.

Get Ingevity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NGVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NGVT vs. The Competition

Export

Metric	Ingevity	CHEM Industry	Materials Sector	NYSE Exchange
Market Cap	$2.33B	$15.13B	$4.93B	$23.18B
Dividend Yield	N/A	1.94%	4.94%	4.09%
P/E Ratio	-18.90	35.08	23.65	30.62
Price / Sales	2.01	2.51	7,505.44	24.75
Price / Cash	5.52	14.68	24.41	19.43
Price / Book	81.13	4.75	9.56	4.70
Net Income	-$167.10M	$376.44M	$156.62M	$1.07B
7 Day Performance	1.28%	1.60%	1.79%	1.14%
1 Month Performance	N/A	N/A	24.17%	1.58%
1 Year Performance	62.80%	21.92%	77.50%	28.06%

Ingevity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NGVT Ingevity	2.3493 of 5 stars	$67.33 -0.7%	$80.00 +18.8%	+64.0%	$2.33B	$1.17B	N/A	1,500
IOSP Innospec	4.3638 of 5 stars	$81.41 +2.3%	N/A	-2.8%	$2.01B	$1.78B	17.74	2,450	Positive News Analyst Upgrade
AVNT Avient	4.6538 of 5 stars	$35.07 +2.2%	$46.40 +32.3%	-1.8%	$3.22B	$3.26B	20.39	9,000	Gap Up
SCL Stepan	2.2147 of 5 stars	$53.41 +2.6%	N/A	-2.6%	$1.21B	$2.33B	N/A	2,328
TKR Timken	4.9237 of 5 stars	$126.96 +5.8%	$139.13 +9.6%	+86.8%	$8.82B	$4.58B	28.85	19,000	Positive News Insider Trade Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NGVT) was last updated on 6/1/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ingevity (NGVT) Competitors